@FierceMedDev: FDA scolds Cepheid for manufacturing issues in Sweden. FierceDiagnostics story | Follow @FierceMedDev
@VarunSaxena2: Updated $ABT's interest in $STJ w/ info from old article on their prior partnership. Neat to add context from 2012. Article | Follow @VarunSaxena2
@EmilyWFierce: ICYMI yesterday: J&J and PCH launch hardware startup accelerator. Story | Follow @EmilyWFierce
> The Chicago, IL-based Propel Center of the iBio Institute has awarded grants to 8 Illinois med tech companies to attend industry conference AdvaMed in San Diego, CA from Oct. 5-7. More
> The FDA has cleared the MagVita TMS Therapy System from MagVenture to treat major depressive disorder in adult patients who don't respond to anti-depressant medication. More
> Symmetry Surgical ($SSRG) has acquired assets from Vesocclude Medical including its product portfolio of titanium ligation clips and appliers for $4 million. More
> Hospira ($HSP) has installed its first Plum 360 infusion system at Shannon Medical Center in San Angelo, Texas. More
Biotech News
@FierceBiotech: UPDATED: Amgen gets a big win with FDA OK for PCSK9 cholesterol drug. Article | Follow @FierceBiotech
@JohnCFierce: Eli Lilly's marginal cancer drug becomes Exhibit A in pricing dilemma. Report | Follow @JohnCFierce
> Stem cell researcher cleared of misconduct after U-turn. Story
> Novo Nordisk buys diabetes startups founded by Lilly R&D veteran. Report
> The FDA offers a controversial solution to the biosimilars name game. Article
Pharma News
@FiercePharma: Patterson shares fall on missed sales and earnings targets. FierceAnimalHealth article | Follow @FiercePharma
@EricPFierce: ICYMI: North Carolina wins Novo prize--$1.2B plant, 700 jobs as Novo builds first US, API plant. Article | Follow @EricPFierce
@CarlyHFierce: Can Sprout's Addyi shrug off serious side effects? These blockbusters did. FiercePharmaMarketing story | Follow @CarlyHFierce
> Celgene nails down $7.2B takeover of Receptos. Item
> J&J brings 500 jobs to Florida with new shared services HQ. More
> Mylan shareholders favor Perrigo takeover. Story
> Sweden's Meda weighs $1B sale of its U.S. business. Article